Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Pharmaceuticals » HPH-990915

  • Global Drug Discovery Market Insights, Opportunities, Analysis, Market Shares and Forecast 2017 – 2023

  • Publish: March 2016 | Report Code: HPH-990915

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

The market for the global drug discovery is highly affected due to the scientific and technological changes and advancements that are continuously taking place around the world. This market contributes highly in the growth of whole pharmaceutical industry as they help in introduction of new drugs. The global drug discovery market is projected to grow impressive during the forecasted period growing at a CAGR of 14.2% during 2016-2023. Adoption of global drug discovery market is driven by following factors: such as rising incidences of chronic diseases, rising demand for novel drug discovery technologies and advancement in field of biotechnology.

There are many forces that drive the global drug discovery market, some of which include the increasing adoption of technology by the researchers in the development of new drugs. The market for HTS (High throughput screening) holds the largest market share, owing to the increased use of the cell based assays and robotics in the parallel screening of the compounds. The increasing geriatric population requires more healthcare facilities and hence demands new drugs to cope up with the various health issues which occur due to aging. The emergence of new diseases such as Ebola and H1N1 swine flu also forces the Pharma companies and research firms to work towards development of newer molecules and target drugs.

The factors the restrain the growth of the global drug discovery market are the slow growth and development of new drugs may hamper the growth of this market. Also, the expiry of patents of the major drugs and the huge cost and time factor that is involved in the drug discovery hamper the growth of the global drug discovery market.

Drug Discovery market is a highly regulated; hence face stringent regulations and approval issues from government authorities. Due to which companies are facing the issue of delayed product launches due to long and expensive approval process.

Source: OBRC Analysis

The drug discovery market has been segmented on the basis of services, science, technology and novel technologies. On the basis of service, market is further sub segmented into:

  • Biological Services
  • Chemical Services
  • Pharmaceutical Services
  • Drug Metabolism and Pharmacokinetics (DMPK) Services





On the basis of science, market is sub segmented into:

  • Proteomics
  • Genomics
  • Bioinformatics




On the basis of technology, market is sub segmented into:

  • QPCR
  • DNA and protein microarrays
  • High-throughput screening
  • Mass spectrometry
  • Laboratory information management systems
  • Microfluidics
  • Gel electrophoresis
  • Chromatography
  • Protein and nucleic acid isolation.
  • Others











On the basis of novel technology, the market is further segmented into:

  • Back scattering interferometry
  • Cantilever array



The drug discovery market is analysed as tissue screening, gene expression profiling, and genetic surrogate for drug action, target validation technologies, antibody-based technology, combinatorial chemistry, SNP genotyping, biochips and microarrays. Some of the major technologies in the drug discovery market are HTS (High throughput screening), QPCR, proteomics, laboratory management information system, DNA and protein microarrays, genomics, gel electrophoresis, protein and nucleic acid isolation, mass spectrometry, micro fluids, and chromatography.

drug discovery The revenue for the above service and science segments are specific to the drug discovery market. however, the total revenue of these segments in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up novel technology segment. Geographically, the drug discovery market is segmented into

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World





North America leads the global drug discovery market due to the presence of manufacturing and research facilities in the region; also, it is the largest consumer of the branded drugs. This region is most lucrative  as large number of  leading pharmaceutical companies presence. North America countries such as U.S. and Canada have formulated policies for encouraging investors for research in  drug development and discovery.  Asia Pacific market is driven by rise in the number contract research organizations. Asia-pacific is fastest growing region in drug discovery market due to presence of skilled labour at affordable cost, rise in disposable income and favourable government policies are also contributing in the drug discovery market growth.

The companies in this industry focus more on innovation and introduction of new products, increasing efficiency and productivity. There are many companies that dwell in this market, some if the key market players include:

  • Sanofi
  • Johnson and Johnson
  • AstraZeneca
  • Bayer
  • BohringerIngheliem
  • Pfizer
  • GlaxoSmithKline
  • Eli Lily
  • Albany Molecular Research
  • Charles River Laboratories











Detailed analysis of these companies provided in this report comprises Overview, SCOT Analysis, Product Portfolio, Strategic Initiative and Strategic Analysis.

These companies using various strategies such as merger & acquisition, collaboration, partnership and product launching.  Such as Sanofi and Exscientia collaborated to deal in drug discovery in May 2017. This collaboration is to develop bispecific-small-molecule drugs. Exscientia is an innovative company of artificial intelligence driven drug discovery.

Why to buy the report:

This report will provide you:

  • Provide in detail the different segments which are affecting the global drug discovery market.
  • Provide you the patent analysis of drug discovery market.
  • Identify, understand, and the strength, opportunities, challenges and threat of the drug discovery market.
  • Provide revenues of major players of the market such as Bayer, Sanofi.
  • Provide you various the regulatory policies which are affecting the global drug discovery market.






How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global drug discovery market offers the longest chain of market segmentation covering major market segmentation based on service science and technology. Report tracks the major market trends in the global drug discovery market such as advancement in field of biotechnology, genomics, molecular biology and so on.   For each market segments covered in global drug discovery market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the drug discovery industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, See Saw analysis, and Porter five force model and so on. For the high-level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global drug discovery market:

  • Increasing adoption of drug discovery technologies such as network security systems and cyber security systems is fuelling growth in global drug discovery market.
  • North America is anticipated to account the largest revenue share in 2016.
  • Collaboration is the key strategy adopted by the various market players of global drug discovery market.
  • High throughput screening holds the largest market share due to increasing applications of robotics and cell based assays.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL DRUG DISCOVERY MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION AND SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. PRICING ANALYSIS
2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES AND ANALYSIS
2.8.2. MARKET SHARE AND TOP COUNTRY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. RISE IN THE AMOUNT OF CHRONIC DISEASES
3.1.2. RISING DEMAND FOR EFFICIENT DRUGS 
3.1.3. ACADEMIA AND PHARMACEUTICAL INDUSTRY ALLIANCE
3.2. MARKET RESTRAINTS
3.2.1. STRINGENT GOVERNMENT REGULATIONS
3.3. MARKET OPPORTUNITIES
3.3.1. ENHANCEMENT IN POPULATION OF AFFLUENT PATIENTS
3.3.2. RISE IN DRUG DISCOVERY OUTSOURCING
3.4.  MARKET CHALLENGES 
3.4.1. HIGH AMOUNT OF INVESTMENT
3.4.2. REQUIRES A LONG TIME SPAN
 
4. MARKET SEGMENTATION 
4.1. GLOBAL DRUG DISCOVERY MARKET BY SERVICE
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL BIOLOGICAL SERVICES MARKET
4.1.5.1.1. APPLICATIONS
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.2. GLOBAL CHEMICAL SERVICES MARKET
4.1.5.2.1. APPLICATIONS
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.2.5. KEY CONCLUSIONS
4.1.5.3. GLOBAL PHARMACEUTICAL SERVICES MARKET
4.1.5.3.1. APPLICATIONS
4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.3.5. KEY CONCLUSIONS
4.1.5.4. GLOBAL DRUG METABOLISM AND PHARMACOKINETICS MARKET
4.1.5.4.1. APPLICATIONS
4.1.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.1.5.4.5. KEY CONCLUSIONS
 
 
 
 
4.2. GLOBAL DRUG DISCOVERY MARKET BY SCIENCE
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL PROTEOMICS MARKET
4.2.5.1.1. APPLICATIONS
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL GENOMICS MARKET
4.2.5.2.1. APPLICATIONS
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL BIOINFORMATICS MARKET
4.2.5.3.1. APPLICATIONS
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.3. GLOBAL DRUG DISCOVERY MARKET BY TECHNOLOGY
4.3.1. MARKET DEFINITION AND SCOPE
4.3.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.3.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.3.4. OPPORTUNITY MATRIX
4.3.5. MARKET SEGMENTATION 
4.3.5.1. GLOBAL QPCR MARKET
4.3.5.1.1. APPLICATIONS
4.3.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.1.5. KEY CONCLUSIONS
4.3.5.2. GLOBAL DNA AND PROTEIN MICROARRAYS MARKET
4.3.5.2.1. APPLICATIONS
4.3.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.2.5. KEY CONCLUSIONS
4.3.5.3. GLOBAL HIGH-THROUGHPUT SCREENING MARKET
4.3.5.3.1. APPLICATIONS
4.3.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.3.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.3.5. KEY CONCLUSIONS
4.3.5.4. GLOBAL MASS SPECTROMETRY MARKET
4.3.5.4.1. APPLICATIONS
4.3.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.4.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.4.5. KEY CONCLUSIONS
4.3.5.5. GLOBAL LABORATORY INFORMATION MANAGEMENT SYSTEMS MARKET
4.3.5.5.1. APPLICATIONS
4.3.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.5.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.5.5. KEY CONCLUSIONS
4.3.5.6. GLOBAL MICROFLUIDICS MARKET
4.3.5.6.1. APPLICATIONS
4.3.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.6.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.6.5. KEY CONCLUSIONS
4.3.5.7. GLOBAL GEL ELECTROPHORESIS MARKET
4.3.5.7.1. APPLICATIONS
4.3.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.7.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.7.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.7.5. KEY CONCLUSIONS
4.3.5.8. GLOBAL CHROMATOGRAPHY MARKET
4.3.5.8.1. APPLICATIONS
4.3.5.8.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.8.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.8.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.8.5. KEY CONCLUSIONS
4.3.5.9. GLOBAL PROTEIN AND NUCLEIC ACID ISOLATION MARKET
4.3.5.9.1. APPLICATIONS
4.3.5.9.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.9.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.9.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.9.5. KEY CONCLUSIONS
4.3.5.10. GLOBAL OTHERS MARKET
4.3.5.10.1. APPLICATIONS
4.3.5.10.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.3.5.10.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.3.5.10.4. TOP PLAYERS & KEY PRODUCTS
4.3.5.10.5. KEY CONCLUSIONS
4.4. GLOBAL DRUG DISCOVERY MARKET BY NOVEL TECHNOLOGIES
4.4.1. MARKET DEFINITION AND SCOPE
4.4.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.4.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.4.4. OPPORTUNITY MATRIX
4.4.5. MARKET SEGMENTATION 
4.4.5.1. GLOBAL BACK SCATTERING INTERFEROMETRY MARKET
4.4.5.1.1. APPLICATIONS
4.4.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.1.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.1.5. KEY CONCLUSIONS
4.4.5.2. GLOBAL CANTILEVER ARRAY MARKET
4.4.5.2.1. APPLICATIONS
4.4.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.4.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.4.5.2.4. TOP PLAYERS & KEY PRODUCTS
4.4.5.2.5. KEY CONCLUSIONS
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITION 
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GLOBAL DRUG DISCOVERY MARKET BY REGION 
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GEOGRAPHIC SEGMENTATION
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.1.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.1.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. ITALY 
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.2.2.6. REST OF EUROPE
6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.6.2. TOP PLAYERS & KEY PRODUCTS
6.4.2.2.6.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.3.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. SOUTH KOREA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.4.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. AUSTRALIA
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.5.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.3.2.6. REST OF ASIA PACIFIC
6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.6.2. TOP PLAYERS & KEY PRODUCTS
6.4.3.2.6.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.4.2.1.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.4.2.2.2. TOP PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. ASTRAZENECA
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. KEY INNOVATION/FOCUS SECTOR
7.1.4. STRATEGIC INITIATIVES 
7.1.5. SCOT ANALYSIS
7.1.6. STRATEGIC ANALYSIS
7.2. ALBANY MOLECULER RESEARCH
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. KEY INNOVATION/FOCUS SECTOR
7.2.4. STRATEGIC INITIATIVES 
7.2.5. SCOT ANALYSIS
7.2.6.  TRATEGIC ANALYSIS
7.3. BAYER
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. KEY INNOVATION/FOCUS SECTOR
7.3.4. STRATEGIC INITIATIVES 
7.3.5. SCOT ANALYSIS 
7.3.6. STRATEGIC ANALYSIS
7.4. BOHRINGERINGHELIEM
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. KEY INNOVATION/FOCUS SECTOR
7.4.4. STRATEGIC INITIATIVES 
7.4.5. SCOT ANALYSIS
7.4.6. STRATEGIC ANALYSIS
7.5. COVANCE
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. KEY INNOVATION/FOCUS SECTOR
7.5.4. STRATEGIC INITIATIVES 
7.5.5. SCOT ANALYSIS
7.5.6. STRATEGIC ANALYSIS
7.6. CYPROTEX
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. KEY INNOVATION/FOCUS SECTOR
7.6.4. STRATEGIC INITIATIVES 
7.6.5. SCOT ANALYSIS
7.6.6. STRATEGIC ANALYSIS
7.7.   ELI LILY
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. KEY INNOVATION/FOCUS SECTOR
7.7.4. STRATEGIC INITIATIVES 
7.7.5. SCOT ANALYSIS
7.7.6. STRATEGIC ANALYSIS
7.8. GLAXOSMITHKLINE PLC
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. KEY INNOVATION/FOCUS SECTOR
7.8.4. STRATEGIC INITIATIVES 
7.8.5. SCOT ANALYSIS
7.8.6. STRATEGIC ANALYSIS 
7.9. GENSCRIPT
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. KEY INNOVATION/FOCUS SECTOR
7.9.4. STRATEGIC INITIATIVES 
7.9.5. SCOT ANALYSIS 
7.9.6. STRATEGIC ANALYSIS
7.10. JOHNSON AND JOHNSON
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. KEY INNOVATION/FOCUS SECTOR
7.10.4. STRATEGIC INITIATIVES 
7.10.5. SCOT ANALYSIS 
7.10.6. STRATEGIC ANALYSIS
7.11. PFIZER, INC.
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. KEY INNOVATION/FOCUS SECTOR
7.11.4. STRATEGIC INITIATIVES 
7.11.5. SCOT ANALYSIS 
7.11.6. STRATEGIC ANALYSIS
7.12. QUINTILES
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. KEY INNOVATION/FOCUS SECTOR
7.12.4. STRATEGIC INITIATIVES 
7.12.5. SCOT ANALYSIS
7.12.6. STRATEGIC ANALYSIS
7.13. VIVA BIOTECH
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. KEY INNOVATION/FOCUS SECTOR
7.13.4. STRATEGIC INITIATIVES 
7.13.5. SCOT ANALYSIS
7.13.6. STRATEGIC ANALYSIS
7.14. WIL RESEARCH LABORATORIES
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. KEY INNOVATION/FOCUS SECTOR
7.14.4. STRATEGIC INITIATIVES 
7.14.5. SCOT ANALYSIS
7.14.6. STRATEGIC ANALYSIS
7.15. WUXI APPTECH
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. KEY INNOVATION/FOCUS SECTOR
7.15.4. STRATEGIC INITIATIVES 
7.15.5. SCOT ANALYSIS
7.15.6. STRATEGIC ANALYSIS
 
LIST OF TABLES
 
1. GLOBAL DRUG DISCOVERY MARKET BY TYPE 2014-2023($ MILLION)
2. GLOBAL CLEAR CELL MARKET BY GEOGRAPHY 2014-2023($ MILLION)
3. GLOBAL PAPILLARY MARKET BY GEOGRAPHY 2014-2023($ MILLION)
4. GLOBAL CHROMOPHOBE MARKET BY GEOGRAPHY 2014-2023($ MILLION)
5. GLOBAL ONCOCYTIC MARKET BY GEOGRAPHY 2014-2023($ MILLION)
6. GLOBAL COLLECTING DUCT MARKET BY GEOGRAPHY 2014-2023($ MILLION)
7. GLOBAL DRUG DISCOVERY MARKET BY BRAND MARKET 2014-2023($ MILLION)
8. GLOBAL NEXAVAR (SORAFENIB) MARKET BY GEOGRAPHY 2014-2023($ MILLION)
9. GLOBAL SUTENT (SUNITINIB) MARKET BY GEOGRAPHY 2014-2023($ MILLION)
10. GLOBAL AFINITOR (EVEROLIMUS) SOLUTIONS MARKET BY GEOGRAPHY 2014-2023($ MILLION)
11. GLOBAL VOTRIENT (PAZOPANIB) MARKET BY GEOGRAPHY 2014-2023($ MILLION)
12. GLOBAL AVASTIN (BEVACIZUMAB) MARKET BY GEOGRAPHY 2014-2023($ MILLION)
13. GLOBAL INLYTA (AXITINIB) MARKET BY GEOGRAPHY 2014-2023($ MILLION)
14. GLOBAL TORISEL (TEMSIROLIMUS) MARKET BY GEOGRAPHY 2014-2023($ MILLION)
15. GLOBAL PROLEUKIN (ALDESLEUKIN) MARKET BY GEOGRAPHY 2014-2023 ($ MILLION)
16. NORTH AMERICA DRUG DISCOVERY MARKET2014-2023 ($MILLION)
17. EUROPE DRUG DISCOVERY MARKET2014-2023 ($MILLION)
18. ASIA PACIFIC DRUG DISCOVERY MARKET2014-2023 ($MILLION)
19. REST OF THE WORLD DRUG DISCOVERY MARKET2014-2023 ($MILLION)
 
LIST OF FIGURES
 
1. GLOBAL DRUG DISCOVERY MARKET BY CLEAR CELLS     2014-2023($ MILLION)
2. GLOBAL DRUG DISCOVERY MARKET BY PAPILLARY   2014-2023 ($ MILLION)
3. GLOBAL DRUG DISCOVERY MARKET BY CHROMOPHOBE  2014-2023 ($ MILLION)
4. GLOBAL DRUG DISCOVERY MARKET BY ONCOCYTIC  2014-2023 ($ MILLION)
5. GLOBAL DRUG DISCOVERY MARKET BY COLLECTING DUCT MARKET  2014-2023($ MILLION)
6. GLOBAL DRUG DISCOVERY MARKET BY NEXAVAR (SORAFENIB) 2014-2023 ($ MILLION)
7. GLOBAL DRUG DISCOVERY MARKET BY SUTENT (SUNITINIB) 2014-2023 ($ MILLION)
8. GLOBAL DRUG DISCOVERY MARKET BY AFINITOR (EVEROLIMUS) 2014-2023 ($ MILLION)
9. GLOBAL DRUG DISCOVERY MARKET BY VOTRIENT (PAZOPANIB) 2014-2023($ MILLION)
10. GLOBAL DRUG DISCOVERY MARKET BY AVASTIN (BEVACIZUMAB) 2014-2023 ($ MILLION)
11. GLOBAL DRUG DISCOVERY MARKET BY INLYTA (AXITINIB) 2014-2023 ($ MILLION)
12. GLOBAL DRUG DISCOVERY MARKET BY TORISEL (TEMSIROLIMUS) 2014-2023 ($ MILLION)
13. GLOBAL DRUG DISCOVERY MARKET BY PROLEUKIN (ALDESLEUKIN) 2014-2023 ($ MILLION)
14. UNITED STATES (U.S.)  DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
15. CANADA DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
16. UNITED KINGDOM (UK) DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
17. FRANCE DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
18. GERMANY DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
19. SPAIN DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
20. ITALY DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
21. ROE DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
22. INDIA DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
23. CHINA DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
24. JAPAN DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
25. KOREA DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
26. AUSTRALIA DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
27. ROAPAC DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
28. LATIN AMERICA DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)
29. MENA DRUG DISCOVERY MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 9713031393

UPCOMING REPORTS

No upcoming reports available under this subcategory.

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 9713031393

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion